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S U M M A R Y
Sporotrichosis is a subacute or chronic fungal infection caused by the ubiquitous fungus Sporothrix
schenckii. Disseminated cutaneous sporotrichosis is an uncommon entity and is usually present in the
immunosuppressed. Here, a case of disseminated cutaneous sporotrichosis in an immunocompetent
patient is reported. This 70-year-old healthy woman presented with multiple painful ulcerated nodules
on her face and upper and lower extremities of 6-month duration, associated with low-grade fever, night
sweats, loss of appetite, and loss of weight. Histopathological examination of the skin biopsy revealed
epidermal hyperplasia and granulomatous inﬂammation in the dermis, with budding yeast. Fungal
culture identiﬁed S. schenckii. She had total resolution of the lesions after 2 weeks of intravenous
amphotericin B and 8 months of oral itraconazole. All investigations for underlying immunosuppression
and internal organ involvement were negative. This case reiterates that disseminated cutaneous
sporotrichosis, although common in the immunosuppressed, can also be seen in immunocompetent
patients.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Sporotrichosis is a subacute or chronic fungal infection caused
by the ubiquitous fungus Sporothrix schenckii. It is the most
common yet the least severe of the deep fungal infections.1 It
occurs worldwide, commonly in tropical and subtropical countries.
Mexico, Central America, South America, and Africa have the
highest numbers of reported cases.1 Sporotrichosis is clinically
categorized into four entities, i.e., ﬁxed cutaneous, lymphocuta-
neous, disseminated cutaneous, and extracutaneous.1,2 Lympho-
cutaneous sporotrichosis is the most common entity.
Disseminated cutaneous sporotrichosis is an uncommon entity
and is usually present only in the immunosuppressed.2 A rare case
of disseminated cutaneous sporotrichosis in an immunocompetent
female is presented herein.
2. Case report
A 70-year-old healthy retired midwife presented with multiple
painful ulcerated nodular lesions on her face and upper and lower
extremities of 6-month duration. She also had low grade fever,
night sweats, loss of appetite, and weight loss of 5 kg in 6 months.
However, she did not have chronic cough, hemoptysis, or history of
contact with tuberculosis patients. Her hobby was gardening,* Tel.: +60 3 26155261; fax: +60 3 26985927.
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doi:10.1016/j.ijid.2011.05.005which she carried out daily. She also had two pet cats at home. She
was teetotal and a non-smoker.
On examination, there were multiple tender ulcerated nodules
on the face, upper limbs, and lower limbs (Figure 1). Lung and
abdominal examinations were clear. No enlarged lymph nodes
were detected.
Blood investigations revealed leukocytosis of 14  109/l,
normochromic normocytic anemia of 9 g/dl, and an elevated
erythrocyte sedimentation rate of 50 mm/h. Other blood investi-
gations including liver function, renal function, fasting blood sugar,
HIV, viral hepatitis screening, neutrophil function test, and
immunoglobulin level were normal. A chest radiograph, sputum
for acid-fast bacilli, and sputum culture were negative. Similarly,
blood and urine cultures for bacteria, viruses, fungi, and
mycobacteria were negative. Ultrasonography of the abdomen
was also normal.
Histopathological examination of the skin biopsy revealed
epidermal hyperplasia and granulomatous inﬂammation in the
dermis. Staining with Grocott’s methenamine silver (GMS) stain
showed the presence of budding yeast. Fungal culture of the skin
specimen identiﬁed Sporothrix schenckii.
The patient was diagnosed with disseminated cutaneous
sporotrichosis and given 2 weeks of intravenous amphotericin B
0.7 mg/kg/day with marked improvement of the skin lesions.
Thereafter she was commenced on oral itraconazole 400 mg daily
for 8 months with total resolution of the skin lesions. Repeat
investigations for underlying immunosuppression and internal
organ involvement were all negative.ses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Multiple erythematous tender ulcerated nodules and plaques on the chin, left foot, and right upper limb.
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Disseminated cutaneous sporotrichosis is rare. It usually occurs
in the context of immunodeﬁciency including HIV infection,
malignancies, organ transplantation, alcoholism, diabetes mellitus,
sarcoidosis, tuberculosis, the use of immunosuppressive agents,
and the administration of tumor necrosis factor-alpha antago-
nists.1,2 It occurs very rarely in immunocompetent patients. In the
current case, it is postulated that the patient’s advanced age
allowed for dissemination and spread of the cutaneous lesions.
Disseminated cutaneous sporotrichosis can be acquired from
skin inoculation or inhalation of the fungus. Cutaneous implanta-
tion usually occurs following traumatic injury, especially from
vegetation and also following scratches and bites from animals,
particularly cats.3 The fungus subsequently spreads to the
lymphatics and blood stream causing dissemination. Alternatively
systemic dissemination occurs via inhalation of the fungus through
the respiratory tract. This route of infection is not unlike the
pathogenesis of other dimorphic fungus-related deep mycoses
such as disseminated histoplasmosis. It is postulated that the
current case acquired the infection through skin inoculation, most
likely via traumatic implantation from the thorns and splinters of
vegetation, as she was an avid gardener.
The effect of S. schenckii on the human immune system is
unknown. However, experiments in rats have shown that Th1 is
activated in the initial phase of infection and Th2 in the later
phase.4 Th1 is activated from week 0 through week 5. This results
in the recruitment of macrophages and promotion of cell-mediated
immunity. From week 5 onwards, Th2 is activated, promoting the
humoral immune response. This explains the higher susceptibility
of patients with HIV/AIDS with deﬁcient T helper cell function to
develop disseminated sporotrichosis.
Disseminated cutaneous sporotrichosis presents with multiple
papules, nodules, plaques, and ulcers. Differential diagnoses of
disseminated cutaneous sporotrichosis include fungal, bacterial,
mycobacterial, and spirochetal infections and inﬂammatorydiseases, e.g., pyoderma gangrenosum, polyarteritis nodosa,
vasculitis, sarcoidosis, Sweet’s syndrome, and prurigo nodularis.1,2
The deﬁnitive diagnosis is obtained via fungal culture for S.
schenckii. A fragment of the skin lesion is incubated at 25 8C with
Sabouraud dextrose agar, producing creamy-white colonies within
5 days, which later turn into black–brown colonies.1 The
conversion of mold to yeast in vitro conﬁrms the diagnosis. Recent
molecular evidence has shown that S. schenckii constitutes a
complex of ﬁve phylogenetic species. This complex includes
Sporothrix albicans, Sporothrix brasiliensis, Sporothrix globosa,
Sporothrix mexicana, and Sporothrix schenckii.5 Identiﬁcation of
individual species is still very academic, but will potentially
explain the virulence of the infection and the different responses to
antifungal agents.
Histopathological examination is usually non-speciﬁc, with the
presence of epithelial hyperplasia, granulomatous inﬂammation,
histiocytic plasma inﬁltration, and occasionally asteroid bodies
resulting from an antigen–antibody reaction.1 The fungus is not
readily visualized on hematoxylin–eosin stain due to the presence
of a polysaccharide coat, and staining with periodic acid–Schiff
(PAS) and GMS offer no additional advantages in most cases.1
However, in the current case it was very fortunate that the fungus
was seen on GMS staining of the histopathological examination.
Treatment of disseminated sporotrichosis consists of initial
treatment with intravenous amphotericin B, followed by oral
itraconazole. Other alternatives include oral terbinaﬁne, saturated
solution of potassium iodide (SSKI), oral ﬂuconazole, or thermal
treatment.1,2
This case illustrates the rarity of an uncommon condition.
Disseminated cutaneous sporotrichosis is a rare variant of
sporotrichosis and this disease occurring in an immunocompe-
tent individual is even more uncommon. A high index of
suspicion is needed for the diagnosis of this condition as the
differential diagnoses are vast. Fungal culture must be added as
an essential investigation in patients presenting in a similar
manner.
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